A molecular approach for identifying individuals with Li-Fraumeni syndrome who have a limited family history

被引：3

作者：

Ang, P. ^{[3
,4
]}

Lim, I. H. K. ^{[3
]}

Yong, R. Y. Y. ^{[5
]}

Lee, A. S. G. ^{[1
,2
]}

机构：

[1] Natl Canc Ctr, Div Med Sci, Mol Oncol Lab, Singapore 169610, Singapore

[2] Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore

[3] Natl Canc Ctr, Dept Med Oncol, Singapore 169610, Singapore

[4] Gleneagles Med Ctr, OncoCare Canc Ctr, Singapore, Singapore

[5] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore

来源：

CLINICAL GENETICS | 2009年 / 75卷 / 03期

关键词：

PEUTZ-JEGHERS-SYNDROME; BREAST-CANCER; TP53; MUTATIONS; GASTRIC-CANCER; P53; POPULATION; RISK; ESOPHAGUS; NEOPLASMS; GENETICS;

D O I：

10.1111/j.1399-0004.2008.01133.x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：294 / 297

页数：4

共 30 条

[1] Genetic susceptibility for breast cancer - Risk assessment and counseling [J].

Ang, P ;

Garber, JE .

SEMINARS IN ONCOLOGY, 2001, 28 (04) :419-433

[2] BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy [J].

Ang, Peter ;

Lim, Irene H. K. ;

Lee, Tze-Chuen ;

Luo, Jie-Ting ;

Ong, Danny C. T. ;

Tan, Puay Hoon ;

Lee, Ann S. G. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (11) :2276-2284

[3]

Bang Yung-Jue, 1995, Journal of Korean Medical Science, V10, P205

[4]

BIRCH JM, 1994, CANCER RES, V54, P1298

[5] Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France) [J].

Breton, J ;

Sichel, F ;

Abbas, A ;

Marnay, J ;

Arsène, D ;

Lechevrel, M .

MUTAGENESIS, 2003, 18 (03) :299-306

[6] Genetics as a tool to improve cancer outcomes: ethics and policy [J].

Burke, W ;

Press, N .

NATURE REVIEWS CANCER, 2006, 6 (06) :476-482

[7] Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes [J].

Evans, DGR ;

Birch, JM ;

Ramsden, RT ;

Sharif, S ;

Baser, ME .

JOURNAL OF MEDICAL GENETICS, 2006, 43 (04) :289-294

[8] Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome [J].

Evans, DGR ;

Birch, JM ;

Thorneycroft, M ;

McGown, G ;

Lalloo, F ;

Varley, JM .

JOURNAL OF MEDICAL GENETICS, 2002, 39 (12) :941-944

[9] Frequency and spectrum of cancers in the Peutz-Jeghers syndrome [J].

Hearle, Nicholas ;

Schumacher, Valerie ;

Menko, Fred H. ;

Olschwang, Sylviane ;

Boardman, Lisa A. ;

Gille, Johan J. P. ;

Keller, Josbert J. ;

Westerman, Anne Marie ;

Scott, RodneyJ. ;

Lim, Wendy ;

Trimbath, Jill D. ;

Giardiello, Francis M. ;

Gruber, Stephen B. ;

Offerhaus, G. Johan A. ;

de Rooij, Felix W. M. ;

Wilson, J. H. Paul ;

Hansmann, Anika ;

Moslein, Gabriela ;

Royer-Pokora, Brigitte ;

Vogel, Tilman ;

Phillips, Robin K. S. ;

Spigelman, Allan D. ;

Houlston, Richard S. .

CLINICAL CANCER RESEARCH, 2006, 12 (10) :3209-3215

[10] A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome [J].

Kim, IJ ;

Kang, HC ;

Shin, Y ;

Park, HW ;

Jang, SG ;

Han, SY ;

Lim, SK ;

Lee, MR ;

Chang, HJ ;

Ku, JL ;

Yang, HK ;

Park, JG .

JOURNAL OF HUMAN GENETICS, 2004, 49 (11) :591-595

← 1 2 3 →